BajajJS, HeumanDM, HylemonPB, et al.The Cirrhosis Dysbiosis Ratio Defines Changes in the Gut Microbiome Associated with Cirrhosis and Its Complications. J. Hepatol., 2014; 60(5): 940–947.
4.
Aron-WisnewskyJ, ClémentK. The gut microbiome, diet, and links to cardiometabolic and chronic disorders. Nat. Rev. Nephrol., 2016; 12(3): 169–181.
5.
JainT, SharmaP, AreAC, et al.New Insights into the Cancer–Microbiome–Immune Axis: Decrypting a Decade of Discoveries. Front. Immunol. 2021; 12: 622064.
6.
HaiserHJ, SeimKL, BalskusEP, TurnbaughPJ. Mechanistic insight into digoxin inactivation by Eggerthella lenta augments our understanding of its pharmacokinetics. Gut Microbes, 2014; 5(2): 233–238.
7.
LiX, ZhangS, GuoG, et al.Gut microbiome in modulating immune checkpoint inhibitors. EBioMedicine, 2022; 82: 104163.
8.
BrozaYY, MochalskiP, RuzsanyiV, et al.Hybrid Volatolomics and Disease Detection. Angew. Chem. Int. Ed. Engl., 2015; 54(38): 11036–11048.
9.
FerrandinoG, OrfI, SmithR, et al.Breath Biopsy Assessment of Liver Disease Using an Exogenous Volatile Organic Compound—Toward Improved Detection of Liver Impairment. Clin. Transl. Gastroenterol., 2020; 11(9): e00239.
